Search

everythinglearnresearchcommunity

for

Search:↓

Nanotechnology in dermatology shows promise for better drug delivery and treatment effectiveness but requires more safety research.

Monitoring new epilepsy drugs after they're sold is crucial to find rare and long-term side effects that initial tests might miss.

The conclusion is that combining social and cultural factors with pharmaceutical research could improve our understanding of how drugs work.

Tofacitinib is effective and has minor, reversible side effects for treating severe hair loss in Iran.

Microneedle technology has advanced for painless drug delivery and sensitive detection but faces a gap between experimental use and clinical needs.

Nanostructured lipid carriers are effective for treating hyperpigmentation in women aged 30-40.

Negative expectations can cause adverse effects in dermatology treatments, like with finasteride for baldness, and careful communication can help reduce these nocebo responses.

Treating stubborn hair loss involves both medical and emotional support options.

Using finasteride or dutasteride may cause long-lasting erectile dysfunction.

Various treatments, including FDA-approved drugs, natural products, and oral supplements, can help with hair loss, but a patient's medical history and potential allergies should be considered when choosing a treatment.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

Nanoparticles improve drug delivery through the skin but more research is needed on their long-term effects and skin penetration challenges.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Isotretinoin was not effective in treating facial lichen planopilaris.

The dutasteride nanoemulsion could improve hair loss treatment by enhancing drug penetration and retention in hair follicles.

Some dermatologists in Saudi Arabia prescribe Tofacitinib for hair loss, but many don't due to its unavailability and safety concerns.

Finasteride helps hair growth in early male baldness, but more long-term research needed.

Etoposide is effective in treating several cancers, especially small cell lung cancer, with acceptable side effects.

The debate on direct-to-consumer pharmaceutical ads continues, with consumers finding them educational and doctors concerned about their impact on patient relationships and medication understanding.

Bimatoprost helped a girl grow her eyelashes back quickly and without serious side effects.

Minoxidil can effectively increase hair growth in early male pattern baldness.

Low SULT activity in hair follicles leads to better response to oral minoxidil for hair loss.

New skin disease treatments using TDDS are improving but face challenges like side effects and high costs.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

Most people using minoxidil for hair loss probably won't see significant improvement.

The Polish Society of Dermatology recommends treatments for alopecia areata that vary by severity, including topical and systemic medications, with long-term maintenance important for management.

Trichotillomania is a chronic hair-pulling disorder, more common in females, treated with therapy and sometimes medication.

New biomaterial treatments for baldness show promise, with options depending on patient needs.

Innovative biomaterials show promise in healing chronic diabetic foot ulcers.